MODULO Trial: Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully Treated With Three-drug Regimens at Inclusion
Latest Information Update: 13 Jun 2025
At a glance
- Drugs Doravirine (Primary) ; Lamivudine (Primary) ; Dolutegravir/lamivudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MODULO
Most Recent Events
- 25 May 2025 Status changed from not yet recruiting to recruiting.
- 20 Jan 2025 New trial record